Sinopharm Group Guangdong Yuexing Co., Ltd. announced that it will receive CNY 130,000,000 on April 19, 2017. The transaction will include participation from China National Accord Medicines Corporation Ltd. (SZSE:000028) to maintain its 100% stake in the company after the transaction. The registered capital of the company will increase from CNY 100,000,000 to CNY 230,000,000. The transaction was approved at the 22nd meeting of the 7th directorate of investor and does not need its shareholders’ approval. The company reported total assets of CNY 774,910,000, net assets of CNY 157,470,000, and revenue of CNY 1,740,630,000 for the year ended December 31, 2016.